$124.78
0%
Price vs. BitRank (Last 150 days)
Data gathered: February 22
Data gathered: February 22
Data Bits
| Total Followers [beta] | N/A | N/A |
| Sentiment | N/A | N/A |
| Google Trends | N/A | N/A |
| 4chan Mentions | N/A | N/A |
| Stocktwits Mentions | N/A | N/A |
| Stocktwits Subscribers | N/A | N/A |
| News Mentions | N/A | N/A |
| Reddit Mentions | N/A | N/A |
| Twitter Mentions | N/A | N/A |
In the news
![]() |
FDA Makes U-Turn Again On Moderna New Flu Vaccine Review, Stock SoarsFebruary 17, 10:20 pm (CET) - Benzinga |
![]() |
PTC Therapeutics Pulls Translarna Bid After FDA Flags Weak ProofFebruary 12, 3:18 pm (CET) - Benzinga |
![]() |
Moderna, Mexico Partner To Boost Local Vaccine ProductionFebruary 9, 9:26 pm (CET) - Benzinga |
Measuring UDOW's Drift, And Leveraged ETF WatchlistJanuary 31, 8:05 pm (CET) - SeekingAlpha |
|
![]() |
The Diversification Role Mid-Cap Stocks Can PlayJanuary 28, 7:50 am (CET) - SeekingAlpha |
![]() |
IBB: Beyond The 2025 Surge, Biotech BreakoutJanuary 26, 1:10 pm (CET) - SeekingAlpha |
My Transition From Ray Dalio's 4-Asset Portfolio To The Barbell AllocationJanuary 25, 11:06 pm (CET) - SeekingAlpha |
|
![]() |
LABD: ETF To Benefit From Downturns In The Biotech IndustryJanuary 25, 5:19 pm (CET) - SeekingAlpha |
![]() |
We Could Be In For A Flat Market In 2026January 25, 7:51 am (CET) - SeekingAlpha |
2025 ETF Wrap-Up And What To Expect In 2026January 21, 3:15 pm (CET) - SeekingAlpha |
|
![]() |
Are Healthcare Stocks Poised To Recover As Policy Fears Stabilize?January 21, 2:07 pm (CET) - SeekingAlpha |
![]() |
BBH: Mature Biotech Exposure, But Limited Growth AheadJanuary 21, 12:26 am (CET) - SeekingAlpha |
![]() |
U.S. Earnings: Broadening StrengthJanuary 12, 2:30 pm (CET) - SeekingAlpha |
![]() |
Healthcare Stocks In Focus: Assessing The Outlook For 2026January 7, 1:30 pm (CET) - SeekingAlpha |
![]() |
Leveraged ETF Drift Watch List And Focus On SQQQJanuary 1, 6:04 pm (CET) - SeekingAlpha |
![]() |
Biotech: Time For A Pause To Start 2026January 1, 2:52 pm (CET) - SeekingAlpha |
About SPDR S&P Biotech ETF
The Fund seeks to replicate as closely as possible the performance of an index derived from the biotechnology segment of a U.S. total market composite index.
| BitRank | 35 / 100 |
| Price | $124.78 |
| Target Price | $116.97 |
| Industry | ETF |
Similar companies
| Company | Price | BitRank | |
|---|---|---|---|
Read more about SPDR S&P Biotech ETF and their total followers [beta], sentiment, google trends, 4chan mentions, stocktwits mentions, stocktwits subscribers, news mentions & reddit mentions, twitter mentions.












